Clinicians

Online health communities have become an essential source of support for many patients navigating chronic or complex conditions. For individuals dealing with gastrointestinal symptoms—often persistent, frustrating, and difficult to diagnose—these groups can offer reassurance, shared experience, and a sense of not being alone. Support matters. Community matters. But there is a growing and under-examined risk…

Small intestinal bacterial overgrowth (SIBO) is increasingly evaluated by clinicians encountering patients with a broad range of gastrointestinal symptoms. Expanded access to hydrogen- and methane-based breath testing has facilitated earlier and more frequent assessment. As breath testing becomes more widely used in clinical practice, careful interpretation and contextual integration become essential. Objective breath gas measurements…

As breath testing continues to expand across gastrointestinal practice, handheld, patient-operated breath testing devices have been entering the market, promising greater access, faster feedback, and more frequent measurement. These tools represent a broader shift toward remote, patient-initiated monitoring within gastrointestinal care. But an important clinical question deserves consideration: Does more measurement always equate to improved…

The following overview reflects common interpretation questions we encounter when reviewing breath test patterns in patients using GLP-1 therapy. Many patients referred for breath testing are now commonly using GLP-1 receptor agonists. As the use of these medications has increased, testing interpretation questions have followed. Many labs began noticing certain patterns shortly after GLP-1 therapies…

SIBO (small intestinal bacterial overgrowth) and IMO (intestinal methanogen overgrowth) pose diagnostic challenges even for experienced practitioners.